Switching Apoe4 To Apoe2 In Adult Mice Reduces Alzheimer’s Pathology And Improves Memory

Trending 3 days ago

By flipping a azygous familial move from APOE4 to APOE2 successful big mice, researchers reversed cardinal Alzheimer’s-like changes successful nan encephalon while revealing nan metabolic trade-offs that early APOE-targeted therapies must safely navigate.

 Lightspring / Shutterstock

Study: APOE4 to APOE2 allelic switching successful mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition. Image Credit: Lightspring / Shutterstock

In a caller study published successful nan journal Nature Neuroscience, a group of researchers investigated whether switching apolipoprotein E4 (APOE4) to apolipoprotein E2 (APOE2) successful big mice improves Alzheimer’s disease-relevant encephalon pathology and cognition, while besides defining systemic lipid effects.

Genetic Risk Landscape of APOE Variants

One successful 3 families knows personification surviving pinch representation loss, and late-onset Alzheimer’s illness affects tens of millions worldwide. The strongest communal familial consequence facet is APOE: nan E4 isoform raises consequence up to thirteen-fold successful homozygotes, while nan E2 isoform lowers consequence and slows decline.

Scientists person projected gene-editing strategies to neutralize APOE4 aliases boost APOE2, however, in vivo tests of whole-body and cell-specific switching person been limited. What group want to cognize is simple: if nan cistron could beryllium switched successful adulthood, would nan encephalon really improve?

Further investigation is needed to measure efficacy, safety, and target compartment types.

Engineering nan APOE4-to-APOE2 Switch Model

Investigators engineered a knock-in "APOE switch" rodent statement (APOE4s2) carrying a floxed quality APOE4 coding exon followed by quality APOE2. A tamoxifen-activable Cre recombinase Estrogen Receptor T (CreERT) enabled temporal power of allelic replacement.

Global switching (APOE4s2G) was achieved by crossing to a ubiquitously expressed CreERT; astrocyte-specific switching (APOE4s2A) utilized Aldehyde Dehydrogenase 1 Family Member L1 (Aldh1l1) promoter-driven Cre recombinase Estrogen Receptor T2 fusion (CreERT2) (Aldh1l1-CreERT2) to chiefly restrict replacement to astrocytes successful nan cardinal nervous system, though immoderate peripheral look occurred.

Validation of Allele Conversion and Systemic Lipid Profiling

Allele conversion was validated successful nan liver and encephalon utilizing quantitative polymerase concatenation guidance (qPCR) and liquid chromatography–tandem wide spectrometry (LC-MS/MS) peptide profiling of APOE successful some encephalon and plasma.

Systemic lipid effects were profiled nether normal chow and Western diets pinch lipoprotein fractionation of very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), and enzyme-linked immunosorbent assay (ELISA) quantification of ApoE (protein) and triglycerides.

Cerebral Lipidomics and Cell-Specific Transcriptomics

Cerebral lipidomics utilized untargeted LC-MS/MS and weighted cistron coexpression web study (WGCNA) focusing connected phosphatidylcholine (PC), phosphatidylethanolamine (PE), ceramide (CER), and lyso-phosphatidylcholine (LPC) species.

Whole-brain single-cell ribonucleic acerb sequencing (scRNA-seq) defined differentially expressed genes and Gene Ontology pathways crossed astrocytes, microglia, oligodendrocytes, endothelial cells, and others. For illness relevance, APOE4s2A mice were crossed pinch nan 5 familial Alzheimer’s illness mutation exemplary (5xFAD).

Cognition was tested by fearfulness conditioning and nan Morris h2o maze. Histopathology quantified amyloid-beta (Aβ 40/42), glial fibrillary acidic macromolecule (GFAP), ionized calcium-binding adapter molecule 1 (IBA1), awesome histocompatibility analyzable people II (MHC-II), plaque-associated ApoE, cerebral amyloid angiopathy (CAA), and zonula occludens-1 (ZO1).

Global Replacement Effects connected Lipids and Brain Pathways

Global induction converted APOE4 to APOE2 efficiently astatine some nan messenger RNA (mRNA) and macromolecule levels successful nan liver and brain, arsenic demonstrated by LC-MS/MS, which revealed that nan immense mostly of detected ApoE peptides were unsocial to ApoE2 post-switch.

Systemically, world switching elevated plasma ApoE and triglycerides and increased VLDL fractions, recapitulating features of type III hyperlipoproteinemia seen successful a subset of APOE2 homozygous humans. In nan brain, untargeted lipidomics revealed selective remodeling, pinch galore phosphatidylcholine and ceramide type altered pursuing nan switch.

A WGCNA bluish lipid module, enriched for PC and PE, correlated pinch nan modulation from ApoE4 to ApoE2, indicating coordinated rewiring of membrane and signaling lipids important for synaptic usability and glial communication.

Adult Transcriptional Shifts After APOE Editing

ScRNA-seq revealed that a one-month move from APOE4 to APOE2 successful adulthood altered encephalon transcriptional programs crossed aggregate compartment types, astir notably astrocytes, oligodendrocytes, microglia, and endothelial cells.

Differentially expressed genes overlapped pinch late-onset Alzheimer’s illness lists from quality datasets and converged connected metabolism, redox control, neurotransmission, and cytoskeleton aliases vascular integrity pathways. These findings show that signatures often attributed to lifelong APOE4 look are amazingly malleable successful adulthood.

Astrocyte-Restricted APOE2 Replacement Effects

Because astrocytes are nan main root of cardinal tense strategy ApoE, nan squad tested an astrocyte-restricted replacement from APOE4 to APOE2. Cell sorting and qPCR confirmed efficient, cell-specific switching pinch a humble displacement astatine nan whole-brain level, accordant pinch astrocyte predominance.

Astrocyte-only switching recapitulated galore of nan world transcriptional changes, including important overlap pinch late-onset Alzheimer’s illness cistron sets and pathway position related to neurotransmission, redox status, and metabolite transport.

Notably, microglia and oligodendrocytes that still expressed APOE4 nevertheless exhibited galore differentially expressed genes, indicating non-cell-autonomous effects of astrocyte-derived ApoE2.

APOE2 Switching Outcomes successful nan 5xFAD Model

In nan 5xFAD model, astrocyte-only switching to ApoE2 resulted successful improved fearfulness conditioning, pinch female mice exhibiting stronger improvements successful contextual and cued memory, but pinch constricted effects successful nan Morris h2o maze. Amyloid pathology decreased: plaque load fell (with higher baseline successful females), and Aβ 40 and Aβ 42 by ELISA were reduced.

Cerebral amyloid angiopathy was not reduced, and tight junction protein ZO1 was unchanged. Gliosis dampened: GFAP and IBA1 declined, activated-response microglia decreased, plaque-associated ApoE diminished, and microglial disease-associated markers Triggering Receptor Expressed On Myeloid cells 2 (TREM2) and C-type Lectin Domain Containing 7A (CLEC7A) were downregulated.

Therapeutic Implications of Post-Developmental APOE Editing

Inducible post-developmental replacement of APOE4 pinch APOE2 successful big mice quickly remodels metabolism, rewires lipid classes cardinal to membranes and signaling, and reprograms cell-type-specific encephalon transcriptomes. Astrocyte-restricted switching unsocial lowers parenchymal amyloid, reduces plaque-proximal gliosis, shifts microglia distant from activated phenotypes, lessens plaque-associated ApoE, and improves associative memory.

These information propose that post-developmental, cell-targeted APOE editing could modify aggregate Alzheimer’s illness pathways astatine once. Translation will require balancing cardinal tense strategy benefits pinch peripheral risks, specified arsenic type III hyperlipoproteinemia and different APOE2-associated disorders (e.g., melanoma, age-related macular degeneration). This will impact considering sex-specific responses and defining dose, timing, durability, and transportation strategies for safe and equitable objective application.

Journal reference:

  • Golden, L. R., Siano, D. S., Stephens, I. O., MacLean, S. M., Saito, K., Nolt, G. L., Funnell, J. L., Pallerla, A. V., Lee, S., Smith, C., Chen, J., Zhu, H., Voy, C., Whitus, C. M., Hernandez, G., Farmer, B. C., Pandya, K., Cowley, D. O., Macauley, S. L., Gordon, S. M., Morganti, J. M., & Johnson, L. A. (2025). APOE4 to APOE2 allelic switching successful mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition. Nat Neurosci. DOI: 10.1038/s41593-025-02094-y, https://www.nature.com/articles/s41593-025-02094-y
More